ERBB2 and Insulin resistance: In two studies of the effects of HFD initiated at 4 weeks of age in mice overexpressing HER2/Neu in the mammary gland [40, 41], HFD promoted tumor development by increasing tumor incidence without increasing tumor cell proliferation, and there was no insulin resistance or hyperinsulinemia.